Please provide your email address to receive an email when new articles are posted on . Oteseconazole, an investigational oral antifungal therapy, was shown to be safe and effective in the treatment ...
DURHAM, N.C.--(BUSINESS WIRE)--Mycovia Pharmaceuticals, Inc. (“Mycovia”) today announced the publication of results from a Phase 2 clinical study of its oral antifungal product candidate oteseconazole ...
Central papillary atrophy, otherwise known as median rhomboid glossitis, exhibits red, atrophic mucosal areas that are typically asymptomatic and located on the midline posterior dorsal surface of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results